102 cases · page 4 of 4
Showing 91–101C-KORE SYSTEMS LIMITED v.NOVAWELL
This procedural order concerns a review request filed by Novawell against an ex parte saisie order granted to C-Kore Systems Limited, the proprietor of European patent EP 2 265 793 relating to subsea apparatus and testing. The Court examined whether Novawell's review request was filed within the 30-day time limit under Rule 197.3 of the Rules of Procedure, addressing when the 'execution of the measures' begins for purposes of calculating that deadline. The Court also considered the criteria for granting the ex parte order, the distinction between preserving evidence and inspection procedures, and the conformity of the saisie carried out by an expert assisted by a bailiff with French national law.
ICPillar LLC v.Respondent
1 Paris Local Division UPC_CFI_495/2023 Procedural Order of the Court of First Instance of the Unified Patent Court delivered on 28/02/2024 APPLICANT ICPillar LLC 4265 San Felipe Street, Suite 1100 77027 - Houston, Texas - US Represented by Lionel Martin RELEVANT OTHER PARTIES ARM Limited 110 Fulbou
Seoul Viosys Co., Ltd v.Laser Components SAS
1 Division locale de Paris UPC_CFI_440/2023 Ordonnance du Tribunal de première instance de la Juridiction unifiée du brevet, rendue le 27/02/2024 DEMANDEUR : 1) Seoul Viosys Co., Ltd 65-16, Sandan-ro 163beon-gil, Danwon-gu - 15429 - Ansan-si, Gyeonggi-do - KR Représenté par Pauline Debré DÉFENDEUR :
Abbott Diabetes Care Inc. v.Dexcom Inc., Dexcom France SAS, Dexcom International Limited
This procedural order concerns an infringement action brought by Abbott Diabetes Care Inc. against three Dexcom entities before the Paris Local Division. The order addresses service difficulties, particularly with Dexcom International Limited in Ireland, and aligns the deadlines for filing the Statement of Defence for all three defendants. The Judge-Rapporteur approved the parties' agreed reasonable extension, setting the starting point for all defendants at 15/01/2024, with the Statement of Defence expected by 15/04/2024.
SAS LASER COMPONENTS v.Seoul Viosys Co., Ltd
In this legal proceeding before Paris (FR) Local Division (decision issued on 2024-02-12) under reference UPC-001614, SAS LASER COMPONENTS appeared in dispute with Seoul Viosys Co., Ltd concerning patent rights and legal remedies.
ICPillar LLC v.Respondent
ICPillar LLC, proprietor of European Patent EP3000239, brought an infringement action against twelve defendants of the ARM group of companies. When standard service methods failed—particularly delivery to Arm Poland Sp. z.o.o. in Poland—the Claimant sought authorization under Rule 275.1 of the Rules of Procedure for alternative methods of service. The Court authorized alternative service only to the extent that the original methods had failed, rejecting the proposed method that merely replicated the already-attempted registered letter approach, and clarified the application of the ten-day delay rule under the Hague Service Convention.
ICPillar LLC v.ARM Limited Apical Limited Arm Poland Sp. z.o.o Simulity Labs Limited Hyperglance limited SVF Holdco
In this legal proceeding before Paris (FR) Local Division (decision issued on 2024-02-12) under reference UPC-001612, ICPillar LLC appeared in dispute with ARM Limited Apical Limited Arm Poland Sp. z.o.o Simulity Labs Limited Hyperglance limited SVF Holdco concerning patent rights and legal remedies.
DexCom, Inc. v.Abbott Scandinavia Aktiebolag, Newyu,Inc., Abbott Laboratories, Abbott, Abbott B.V., Abbott Oy, Abbott Diagnostics GmbH, Abbott Gesellschaft m.b.H., Abbott S.r.l., Abbott France, Abbott GmbH, Abbott Laboratories A/S, Abbott Diabetes Care Inc., Abbott
This procedural order concerns an infringement action brought by DexCom, Inc. against fourteen defendants, including multiple Abbott entities and Newyu, Inc., regarding European Patent EP3831282. The dispute centered on the alignment of deadlines for filing the Statement of Defence (SoD) across all defendants, given that service on some defendants was delayed or still in progress. Following a case management meeting where all parties orally agreed on a reasonable extension date, the Judge-Rapporteur ordered that the time limit for filing the SoD be aligned for all defendants, with the starting point set at 15 December 2023 and the SoD expected by 15 March 2024.
Dexcom, Inc. v.Abbott Laboratories, Abbott Diabetes Care inc, Abbott France, Abbott NV/SA, Abbott B.V, Abbott S.r.l, Abbott Sacandinavia Aktiebolag, Abbott GmbH, Abbott Diagnostics Gmbh, Abbott Logistics B.V
This is a procedural order from the Paris Local Division concerning an infringement action brought by DexCom, Inc. against fourteen defendants, primarily comprising various Abbott entities and Newyu, Inc., regarding European Patent EP3831282. The order addresses service difficulties and aligns the deadline for filing the Statement of Defence across all defendants. The Judge-Rapporteur accepted the parties' agreed extension, setting the Statement of Defence deadline to 15 March 2024, with the starting point aligned to 15 December 2023.
Dexcom, Inc. v.Abbott Laboratories, Abbott Diabetes Care inc, Abbott France, Abbott NV/SA, Abbott B.V, Abbott S.r.l, Abbott Sacandinavia Aktiebolag, Abbott GmbH, Abbott Diagnostics Gmbh, Abbott Logistics B.V
This is a procedural order from the Paris Local Division concerning an infringement action brought by DexCom, Inc. against fourteen defendants, primarily comprising various Abbott entities and Newyu, Inc., regarding European Patent EP3831282. The order addresses service difficulties and aligns the deadline for filing the Statement of Defence across all defendants. The Judge-Rapporteur accepted the parties' agreed extension, setting the Statement of Defence deadline to 15 March 2024, with the starting point aligned to 15 December 2023.
Dexcom, Inc. v.Abbott Laboratories, Abbott Diabetes Care inc, Abbott France, Abbott NV/SA, Abbott B.V, Abbott S.r.l, Abbott Sacandinavia Aktiebolag, Abbott GmbH, Abbott Diagnostics Gmbh, Abbott Logistics B.V
This is a procedural order from the Paris Local Division concerning an infringement action brought by DexCom, Inc. against fourteen defendants, primarily comprising various Abbott entities and Newyu, Inc., regarding European Patent EP3831282. The order addresses service difficulties and aligns the deadline for filing the Statement of Defence across all defendants. The Judge-Rapporteur accepted the parties' agreed extension, setting the Statement of Defence deadline to 15 March 2024, with the starting point aligned to 15 December 2023.
HEWLETT-PACKARD DEVELOPMENT COMPANY, L.P v.LAMA FRANCE
1 Division locale de Paris UPC_CFI_358/2023 Ordonnance de procédure du Tribunal de première instance de la Juridiction unifiée du brevet, rendue le 02/08/2024 concernant R.191 RdP DEMANDEUR HEWLETT-PACKARD DEVELOPMENT COMPANY, L.P 10300 Energy Drive, Spring, Harris County, TX, 77389, USA - 77389 - H
Facing a similar IP matter?
Arctic Invent is a specialist IP firm with deep litigation expertise across India, EU, US, and UK. Our team uses data-driven strategy to build stronger cases.